3 results
The primary objective is to determine the effect of co-administration of telepravir, given as 2 tablets of 375 mg every 8 hours and DRV/rtv or fAPV/rtv on the amount of telaprevir and DRV/rtv or fAPV/rtv in the body. The secondary objective is to…
The primary objective is to assess the usability and feasibility of the VITAAAL intervention as blended-care intervention. Secondary/exploratory objectives are to evaluate clinical outcomes (e.g. Time in Range, estimated HbA1c, body weight, and…
Phase 1. The primary objective is to asses the usability of the Diameter in secondary care to solve main user problems before the start of the second phase. Phase 2. The primary objective is to assess intervention usage and acceptability of the…